Bruck Claudine 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 7, 2020
Insider Transaction Report
Form 4
Bruck Claudine
Director
Transactions
- Award
Common Stock
2020-02-06$0.00/sh+2,500$3→ 10,050 total - Award
Stock Option
2020-02-06$0.00/sh+2,500$3→ 7,500 totalExercise: $1.06From: 2021-02-06Exp: 2030-02-06→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the on-year anniversary of the date of grant.